Literature DB >> 3920817

The blood microvasculature in T-cell lymphomas. A morphological, ultrastructural and immunohistochemical study.

C Kittas, M L Hansmann, B Borisch, A C Feller, K Lennert.   

Abstract

The microvasculature of lymph nodes of 55 cases of T-cell lymphoma was studied by light microscopy, immunohistochemistry and electron microscopy. A modified peroxidase-antiperoxidase (PAP) method was used for staining paraffin sections with lectin I of Ulex europaeus (UEA-I), which is a specific marker for vascular endothelial cells. The T-cell nature of each case was proven by immunohistochemistry, including immunoperoxidase staining of frozen sections with monoclonal T-cell antibodies. The cases were subclassified according to previously established criteria, but with the addition of a separate group showing a high content of clear cells. For the purpose of the present study, the small blood vessels were separated into two main variants, viz.: high endothelial venules (HEV) and all other types of vessels with flat endothelium (SVFE). The development of each of these variants and the extent of lymphocyte migration through the vascular wall were assessed semiquantitatively. The findings suggest that the blood microvasculature, as a whole, is similar in all types of T-cell lymphoma. There were distinct differences, however, in the development of the two main categories of small vessels between the various types. Chronic lymphocytic leukaemia of T-type (T-CLL) and Sézary's syndrome were poor in SVFE and rich in HEV, and there was considerable lymphocyte traffic through the latter. In contrast, T-immunoblastic and especially T-lymphoblastic lymphocyte traffic. The appearance of the microvasculature varied markedly in the various subtypes of "pleomorphic T-cell lymphoma". In the small cell subtype HEV predominated and SVFE represented only a small or moderate fraction of the microvasculature. As the size of the neoplastic lymphoid cells increased towards the medium-sized and large cell subtype, there was a decrease in the number of HEV and an increase in the number of SVFE accompanied by a decrease in lymphocyte migration. In T-cell lymphoma of the clear cell type the microvasculature showed features between those of T-CLL and the small cell subtype of pleomorphic T-cell lymphoma. Electron microscopy confirmed the light microscopic findings and revealed many similarities in vascular changes between "pleomorphic T-cell lymphomas" and lymphogranulomatosis X.

Entities:  

Mesh:

Year:  1985        PMID: 3920817     DOI: 10.1007/bf00737170

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  36 in total

1.  Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease.

Authors:  R J Lukes; B H Tindle
Journal:  N Engl J Med       Date:  1975-01-02       Impact factor: 91.245

2.  The symbiosis of immunocompetent and endothelial cells.

Authors:  W M Baldwin
Journal:  Immunol Today       Date:  1982-10

3.  Post-capillary venules as the pathway for migrating B lymphocytes.

Authors:  M Kotani; Y Nawa; H Fujii; T Fukumoto; M Miyamoto
Journal:  Cell Tissue Res       Date:  1974       Impact factor: 5.249

4.  Histochemical studies of high-endothelial venules of lymph nodes and Peyer's patches in the mouse.

Authors:  C Röpke; O Jorgensen; M H Claësson
Journal:  Z Zellforsch Mikrosk Anat       Date:  1972

5.  An electron microscopic study of the changes induced by oestrogens on the lymph-node post-capillary venules.

Authors:  C Kittas; L Henry
Journal:  J Pathol       Date:  1979-09       Impact factor: 7.996

6.  Angioimmunoblastic lymphadenopathy: an ultrastructural and immunologic study with review of the literature.

Authors:  R S Neiman; P Dervan; C Haudenschild; R Jaffe
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

7.  Plasmacytoid T-cell clusters in non-specific lymphadenitis.

Authors:  R Vollenweider; K Lennert
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1983

8.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

9.  Glycoconjugate with Ulex europaeus agglutinin-I-binding sites in normal mucosa, adenoma, and carcinoma of the human large bowel.

Authors:  S Yonezawa; T Nakamura; S Tanaka; E Sato
Journal:  J Natl Cancer Inst       Date:  1982-10       Impact factor: 13.506

10.  Blood microcirculation in the lymph node during the primary immune response.

Authors:  P G Herman; I Yamamoto; H Z Mellins
Journal:  J Exp Med       Date:  1972-10-01       Impact factor: 14.307

View more
  5 in total

1.  Lectin I of Ulex europaeus as a marker for a subset of histiocytic tumours of the lymph node.

Authors:  L P Ruco; E Pescarmona; F Pezzella; S Uccini; A M Testi; C Cartoni; C D Baroni
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

Review 2.  Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification.

Authors:  T Suchi; K Lennert; L Y Tu; M Kikuchi; E Sato; A G Stansfeld; A C Feller
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

3.  Expression of adhesion molecules in primary B-cell gastric lymphoma and lymphoid follicles.

Authors:  Y Sato; M Ito; K Morise; Y Saito; K Kusugami
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

4.  Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas?

Authors:  D Ribatti; B Nico; A Vacca; A Marzullo; N Calvi; L Roncali; F Dammacco
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

5.  Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas.

Authors:  A Vacca; D Ribatti; L Ruco; F Giacchetta; B Nico; F Quondamatteo; R Ria; M Iurlaro; F Dammacco
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.